Teva buys Anda for $500 million
Mega acquisition by Israeli company comes one day after final purchase of Allergan’s generic medicines producer, Actavis Generics.
Mega acquisition by Israeli company comes one day after final purchase of Allergan’s generic medicines producer, Actavis Generics.
‘We are making this acquisition to give customers a new level of protection against threats through better visibility into their identity infrastructure.’